Search
for
Sort by
Research 61–90 of 1000+
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- 0917 Finasteride is Associated with a Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Medical treatments for male and female pattern hair loss
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Liposomes in dermatology today
- The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization
- Folliculitis decalvans
- Androgenetic Alopecia: An Update of Treatment Options
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Alopecia Areata: An Updated Review for 2023
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Expert System for Hair Loss Diagnosis and Treatment
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Pinpoint white dots in the scalp: Dermoscopic and histopathologic correlation
- Low level laser therapy and hair regrowth: an evidence-based review
- Common causes of hair loss – clinical manifestations, trichoscopy and therapy
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases
- Skin Permeation of Small-Molecule Drugs, Macromolecules, and Nanoparticles Mediated by a Fractional Carbon Dioxide Laser: The Role of Hair Follicles
- Nanotechnology-Based Cosmetics for Hair Care
- Odontogenic Potential of Mesenchymal Cells from Hair Follicle Dermal Papilla
- Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up
- Alopecia: A review of laser and light therapies